n-acetylaspartic acid has been researched along with Multiple Sclerosis in 139 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 35 (25.18) | 18.2507 |
2000's | 65 (46.76) | 29.6817 |
2010's | 39 (28.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bera, G; Bodini, B; Branzoli, F; Didier, M; García-Lorenzo, D; Lehericy, S; Lubetzki, C; Maillart, E; Poirion, E; Ronen, I; Socha, J; Stankoff, B | 1 |
Cortese, ICM; Ercan, E; Reich, DS; Ronen, I; Sati, P; Wood, ET | 1 |
Alkhayer, K; Clements, R; Freeman, E; McDonough, J; Shelestak, J; Singhal, NK | 1 |
Huang, JK; Rosko, L; Smith, VN; Yamazaki, R | 1 |
Grendar, M; Hnilicova, P; Kantorova, E; Kurca, E; Polacek, H; Zelenak, K | 1 |
Cambron, M; D'haeseleer, M; De Keyser, J; Fierens, Y; Hoogduin, JM; Koch, MW; Steen, C; van Osch, MJ | 1 |
Aalto, A; Landtblom, AM; Leinhard, OD; Lundberg, P; Smedby, Ö; Tisell, A; Warntjes, JB | 1 |
Amato, MP; Bartolozzi, ML; Battaglini, M; De Stefano, N; Gasperini, C; Giorgio, A; Hakiki, B; Malentacchi, G; Portaccio, E; Rossi, F; Santangelo, M; Stromillo, ML | 1 |
Bellenberg, B; Busch, M; Chan, A; Gold, R; Lukas, C; Trampe, N | 1 |
Alonso, J; Rovira, A | 1 |
Róg, T; Szafirska, M; Urbanik, A | 1 |
Boyko, AN; Comi, G; De Stefano, N; Filippi, M; Jeffery, D; Kappos, L; Montalban, X; Pagani, E; Rocca, MA | 1 |
Clements, R; Freeman, E; Gregory, R; Li, S; McDonough, J; Sulak, M | 1 |
Bilinska, M; Bladowska, J; Gruszka, E; Podemski, R; Pokryszko-Dragan, A; Sasiadek, M; Slotwinski, K; Zagrajek, M; Zimny, A | 1 |
Blinkenberg, M; Hanson, LG; Mathiesen, HK; Paulson, OB; Skimminge, A; Sorensen, PS; Wu, X | 1 |
Brenneman, D; Cree, BA; Hauser, SL; Kornak, J; Llufriu, S; Nelson, SJ; Oh, J; Pelletier, D; Ratiney, H; Sampat, M | 1 |
Azevedo, CJ; Chu, P; Cree, BA; Hauser, SL; Kornak, J; Nelson, SJ; Okuda, DT; Pelletier, D; Sampat, M | 1 |
Bellini, T; Blankenstein, MA; Comabella, M; Killestein, J; Koel-Simmelink, MJ; Korth, C; Montalban, X; Ottis, P; Roos, B; Rovira, A; Teunissen, CE; Tintoré, M; Trentini, A | 1 |
Denic, A; Rodriguez, M; Warrington, AE; Watzlawik, JO; Wootla, B | 1 |
Alavijeh, SK; Ebrahimzadeh, SA; Faeghi, F; Harirchian, MH; Madadi, A; Rad, HS; Rahimian, N; Vafaeyan, H | 1 |
Alt, J; Hollinger, KR; Kaplin, AI; Riehm, AM; Slusher, BS | 1 |
Beaulieu, C; Giuliani, F; Hanstock, C; Kalra, S; Zaini, WH | 1 |
Botzkowski, D; Gass, A; Kuhle, J; Müller, S; Pardini, M; Putzki, N; Ruberte, E; Tettenborn, B; Valmaggia, C; Vehoff, J; Würfel, J; Yaldizli, Ö | 1 |
Bannerman, P; Burns, T; Clements, R; Daniels, A; Freeman, E; Gadd, J; Guo, F; Huang, H; Kooijman, EE; Li, S; McDonough, J; Pleasure, D; Shriver, L; Singhal, NK | 1 |
Chen, H; Dong, H; Duan, Y; Huang, J; Li, K; Liu, Y; Liu, Z; Ren, Z; Sun, Z; Ye, J | 1 |
Ağildere, M; Arat, Z; Benli, US; Cakir, B; Can, U; Toprak, MK; Ulu, EM | 1 |
Blom, HJ; Bouwman, F; Brundin, L; Dijkstra, CD; Iacobaeus, E; Jakobs, C; Khademi, M; Koel-Simmelink, MJ; Norgren, N; Schepens, M; Teunissen, CE; Twaalfhoven, HA | 1 |
Benedetti, B; Bertolotto, A; Capra, R; Caputo, D; Comi, G; Filippi, M; Martinelli, V; Rocca, MA; Rovaris, M; Zaffaroni, M | 1 |
Babb, JS; Gonen, O; Herbert, J; Kirov, II; Patil, V; Rusinek, H | 1 |
Celda, B; Martínez-Bisbal, MC | 1 |
Geurts, JJ; van Horssen, J | 1 |
De Keyser, J; Hoogduin, JM; Koch, M; Steen, C; Wilczak, N | 1 |
Baranzini, SE; Hauser, SL; Khankhanian, P; Matthews, PM; Nelson, SJ; Oksenberg, JR; Okuda, DT; Pelletier, D; Srinivasan, R | 1 |
Brief, EE; Laule, C; Li, DK; Mackay, AL; Vavasour, IM | 1 |
Babb, JS; Benedetti, B; Falini, A; Filippi, M; Gonen, O; Grossman, RI; Rigotti, DJ | 1 |
Audoin, B; Confort-Gouny, S; Cozzone, PJ; Crespy, L; Faivre, A; Le Fur, Y; Malikova, I; Pelletier, J; Ranjeva, JP; Reuter, F; Rico, A; Soulier, E; Viout, P; Zaaraoui, W | 1 |
Bellmann-Strobl, J; Bock, M; Brandt, AU; Dörr, J; Ittermann, B; Mohr, C; Paul, F; Pfueller, CF; Schubert, F; Schwenteck, T; Waiczies, H; Walaszek, B; Weinges-Evers, N; Wuerfel, JT | 1 |
Achtnichts, L; Amann, M; Babb, JS; Gass, A; Gonen, O; Hirsch, J; Inglese, M; Kappos, L; Naegelin, Y; Rigotti, DJ | 1 |
Chatterjee, S; Kesavadas, C; Saini, J; Thomas, B | 1 |
Bieber, A; Denic, A; Macura, S; Pirko, I; Rodriguez, M; Wootla, B | 1 |
Bagory, M; Comte, JC; Confavreux, C; Cotton, F; Durand-Dubief, F; Hannoun, S; Ibarrola, D; Sappey-Marinier, D | 1 |
Barker, PB; Calabresi, P; Harrison, D; Jones, CK; Reich, DS; Ronen, I; Techawiboonwong, A; Wood, ET | 1 |
Boĭko, AN; Davydovskaia, MV; Gusev, EI; Kornienko, VN; Podoprigora, AE; Pronin, IN | 1 |
Linssen, WH; Pouwels, PJ; van Oosten, BW; Visser, F; Wattjes, MP | 1 |
Brex, PA; Chard, D; Dalton, C; Griffin, CM; Kapeller, P; McLean, MA; Miller, DH; Parker, GJ; Thompson, AJ | 1 |
Alberti, A; Chiarini, P; Gallai, V; Gobbi, G; Pelliccioli, GP; Presciutti, O; Sarchielli, P; Tarducci, R | 1 |
Genain, C; Goodkin, DE; Grenier, D; Lu, Y; Nelson, SJ; Pelletier, D | 1 |
Enzinger, C; Fazekas, F; Hartung, HP; Kapeller, P; Poltrum, B; Ropele, S; Schmidt, H; Schmidt, R; Strasser-Fuchs, S | 1 |
Bozzali, M; Comi, G; Falini, A; Filippi, M; Ghezzi, A; Gonen, O; Grossman, RI; Kesavadas, C; Martinelli, V; Rovaris, M; Scotti, G | 1 |
Arnold, D; Blamire, AM; Corkill, R; Matthews, PM; Narayanan, S; Palace, J; Parry, A; Styles, P | 1 |
Lassmann, H | 1 |
Comi, G; Falini, A; Filippi, M; Ghezzi, A; Martinelli, V; Mezzapesa, DM; Rocca, MA; Scotti, G | 1 |
Harting, I; Meyding-Lamadé, U; Sartor, K; Sellner, J | 1 |
Christodoulou, C; Huang, W; Krupp, LB; Li, L; Li, X; Liang, Z; MacAllister, WS; Melville, P; Morgan, T; Peyster, R; Roche, P; Roque, C; Scherl, WF; Tudorica, LA | 1 |
Antel, JP; Goodkin, DE; Kita, M; Nelson, SJ; Oh, J; Pelletier, D; Zamvil, SS | 1 |
Babb, JS; Gonen, O; Grossman, RI; Inglese, M; Li, BS; Rusinek, H | 1 |
Ahmed, Z; Baker, D; Croxford, JL; Cuzner, ML; Giovannoni, G; Hankey, DJ; Jackson, SJ; Ledent, C; Petzold, A; Pocock, JM; Pryce, G; Thompson, AJ | 1 |
Fukatsu, H; Iijima, M; Ito, T; Mabuchi, N; Sobue, G; Watanabe, H | 1 |
Zaffaroni, M | 1 |
Bartolozzi, ML; De Stefano, N; Federico, A; Guidi, L; Stromillo, ML | 1 |
Arnold, DL; De Stefano, N; Francis, SJ; Lapierre, Y; Narayanan, S; Santos, AC; Tartaglia, MC | 1 |
Mazurek, AA | 1 |
Gamez, J; Johnson, A; Macura, SI; Pirko, I; Rodriguez, M | 1 |
Babb, JS; Ge, Y; Gonen, O; Grossman, RI; Inglese, M; Markowitz, CE | 1 |
Chard, DT; Dalton, CM; Fernando, KT; Gordon, RM; MacManus, DG; McLean, MA; Miller, DH; Miszkiel, KA; Plant, GT; Thompson, AJ | 1 |
Antel, JP; Arnold, DL; Brass, SD; Collins, L; Lapierre, Y; Narayanan, S | 1 |
Huvaj, S; Kendi, AT; Kendi, M; Tan, FU; Tellioğlu, S; Yilmaz, S | 1 |
Dijkstra, C; Polman, C; Teunissen, CE | 1 |
Barkhof, F; Castelijns, JA; Polman, CH; Pouwels, PJ; Uitdehaag, BM; Vrenken, H | 1 |
Antel, JP; Arnold, DL; Biernacki, K; Blain, M; Narayanan, S; Prat, A | 1 |
De Keyser, J; Mostert, JP; Oudkerk, M; Sijens, PE | 2 |
Arnold, DL; Caramanos, Z; Narayanan, S | 1 |
Barkhof, F; Castelijns, JA; Geurts, JJ; Polman, CH; Pouwels, PJ; Reuling, IE; Uitdehaag, BM; Vrenken, H | 1 |
Criste, GA; Trapp, BD | 1 |
Cianfoni, A; Imbesi, SG; Niku, S | 1 |
Barkhof, F; Dijkstra, CD; Eikelenboom, MJ; Jakobs, C; Jasperse, B; Polman, CH; Teunissen, CE; Uitdehaag, BM | 1 |
De Stefano, N; Filippi, M | 1 |
Ali-Cherif, A; Audoin, B; Confort-Gouny, S; Cozzone, PJ; Le Fur, Y; Malikova, I; Pelletier, J; Ranjeva, JP; Soulier, E; Van Au Duong, M; Viout, P | 1 |
Harzheim, M; Klotz, L; Lutterbey, GG; Schild, HH; Träber, F; Wattjes, MP | 1 |
Bagory, M; Confavreux, C; Durand-Dubief, F; Ibarrola, D; Sappey-Marinier, D | 1 |
Bogdanow, M; Harzheim, M; Lutterbey, GG; Schild, HH; Träber, F; Wattjes, MP | 1 |
Bao, F; Caon, C; Khan, O; Latif, Z; Shen, Y; Tselis, A; Zak, I | 1 |
Blaauw, Y; De Keyser, J; Hoogduin, JM; Koch, MW; Kuiper, AJ; Mostert, JP | 1 |
Miller, DH | 1 |
Clark, JB; Davies, SE; McDonald, WI; Newcombe, J; Williams, SR | 1 |
Cohen, JA; Dousset, V; Gonzalez-Scarano, F; Grossman, RI; Hiehle, JF; Lenkinski, RE; Ramer, KN; Schnall, MD | 1 |
Antel, JP; Arnold, DL; Collins, DL; Francis, GS; Matthews, PM; Riess, GT; Wolfson, C | 1 |
de Bie, SH; Fein, G; Goodin, DS; Hugg, JW; Husted, CA; Matson, GB; Maudsley, AA; Tsuruda, JS; Weiner, MW | 1 |
Maudsley, AA; Meyerhoff, DJ; Weiner, MW; Wu, Z | 1 |
Barker, GJ; Brennan, A; Davie, CA; Hawkins, CP; McDonald, WI; Miller, DH; Tofts, PS | 1 |
Barker, GJ; Davie, CA; Harding, AE; McDonald, WI; Miller, DH; Thompson, AJ; Tofts, PS; Webb, S | 1 |
Antel, J; Arnold, DL; De Stefano, N; Francis, G; Fu, L; Matthews, PM; Narayanan, S; Pioro, E; Wolfson, C | 1 |
Adams, D; Hetherington, HP; Mason, GF; Pan, JW; Pohost, GM; Twieg, DB; Vaughn, MJ | 1 |
Hetherington, HP; Mitchell, G; Pan, JW; Pohost, GM; Vaughan, JT; Whitaker, JN | 1 |
Landtblom, AM; Nyland, H; Sjöqvist, L; Söderfeldt, B; Thuomas, KA | 1 |
Gonzalez-Scarano, F; Grossman, RI; Kimura, H; Lenkinski, RE | 1 |
Cabanis, EA; Iba-Zizen, MT; Lyon-Caen, O; Stievenart, JL; Tourbah, A; Zannoli, G | 1 |
Antel, JP; Arnold, DL; Collins, DL; De Stefano, N; Francis, GS; Fu, L; Matthews, PM; Narayanan, S; Pioro, E | 1 |
Arnold, DL; Collins, DL; De Stefano, N; Fu, L; Narayanan, S; Wolfson, C; Worsley, KJ | 1 |
Antel, JP; Arnold, DL; De Stefano, N; Francis, GS; Matthews, PM; Narayanan, S | 2 |
's Gravenmade, EJ; den Boer, JA; Geelen, JA; Minderhoud, JM; Peters, AR; Prevo, RL | 1 |
Doyle, TJ; Lai, D; Narayana, PA; Wolinsky, JS | 1 |
Calabrese, G; Colombo, B; Comi, G; Falini, A; Filippi, M; Lipari, S; Origgi, D; Scotti, G | 1 |
Antel, JP; Arnold, DL; De Stefano, N; Francis, GS; Fu, L; Matthews, PM; Narayanan, S; Wolfson, C; Worsley, KJ | 1 |
Antel, JP; Arnold, DL; De Stefano, N; Francis, GS; Fu, L; Matthews, PM; Narayanan, S; Stanley, J | 1 |
Hetherington, HP; Pan, JW; Twieg, DB | 1 |
Heide, AC; Kraft, GH; Richards, TL | 1 |
Davie, CA; Foong, J; Miller, DH; Ron, MA; Rozewicz, L; Thompson, AJ | 1 |
Alberti, A; Chiarini, P; Gallai, V; Gobbi, G; Pelliccioli, GP; Presciutti, O; Sarchielli, P; Tarducci, R; Vicinanza, F | 1 |
Antel, JP; Arnold, DL; de Stefano, N; Francis, GS; Narayanan, S; Pike, GB | 1 |
Bitsch, A; Brück, W; Bruhn, H; Frahm, J; Lassmann, H; Stringaris, A; Vougioukas, V | 1 |
Blamire, AM; Ho, KH; Lee, MA; Matthews, PM; Mills, KR; Palace, J; Pendlebury, S; Styles, P | 1 |
Babb, JS; Catalaa, I; Ge, Y; Gonen, O; Grossman, RI; Kolson, DL; Mannon, LJ | 1 |
Helms, G; Kivisäkk, P; Link, H; Stawiarz, L | 1 |
Blamire, AM; Lee, MA; Matthews, PM; Pendlebury, ST; Styles, P | 1 |
Barker, GJ; Brex, PA; Leary, SM; MacManus, DG; Miller, DH; Parker, GJ; Thompson, AJ | 1 |
Alonso, J; Cucurella, MG; Montalbán, X; Pedraza, S; Río, J; Rovira, A; Tintoré, MM | 1 |
Barker, GJ; Duncan, JS; McLean, MA; Woermann, FG | 1 |
Antel, J; Arnold, DL; Arnoutelis, R; Jenkinson, M; Matthews, PM; Narayanan, S; Reddy, H | 1 |
Bjartmar, C; Kidd, G; Mörk, S; Rudick, R; Trapp, BD | 1 |
Bellacosa, A; Carrara, D; Federico, F; Giannini, P; Liguori, M; Livrea, P; Lucivero, V; Simone, IL; Tortorella, C | 1 |
Antel, JP; Arnaoutelis, R; Arnold, DL; De Stefano, N; Francis, GS; Matthews, PM; Narayanan, S; Tartaglia, MC | 1 |
Arnold, DL; Bartolozzi, ML; De Stefano, N; Federico, A; Guidi, L; Mortilla, M; Narayanan, S | 1 |
Grodd, W; Klose, U; Mader, I; Melms, A; Naegele, T; Seeger, U; Weissert, R | 1 |
Arnold, DL; De Stefano, N; Matthews, PM; Narayanan, S | 1 |
Bjartmar, C; Trapp, BD | 1 |
Arnold, DL; Matthews, PM | 1 |
Bartolozzi, ML; Comi, G; De Stefano, N; Federico, A; Filippi, M; Guidi, L; Iannucci, G; Mainero, C; Sormani, MP | 1 |
Coyle, PK; Elkins, LE; Krupp, LB; Pan, JW | 1 |
Antel, JP; Arnaoutelis, R; Arnold, DL; Caramanos, Z; Collins, DL; De Stefano, N; Francis, GS; Narayanan, S; Pelletier, D | 1 |
Matthews, PM | 1 |
Antel, JP; Arnold, DL; Francis, GS; Matthews, PM; O'Connor, J | 1 |
Narayana, PA; Wolinsky, JS | 1 |
Christiansen, P; Frederiksen, J; Heltberg, A; Henriksen, O; Jensen, M; Larsson, HB; Olesen, J | 1 |
Richards, TL | 1 |
Baert, AL; Carton, H; Demaerel, P; Johannik, K; Marchal, G; Van Hecke, P; Wilms, G | 1 |
Antel, J; Arnold, DL; Francis, G; Matthews, PM | 1 |
18 review(s) available for n-acetylaspartic acid and Multiple Sclerosis
Article | Year |
---|---|
Oligodendrocyte Bioenergetics in Health and Disease.
Topics: Animals; Aspartic Acid; Axons; Brain; Energy Metabolism; Glucose; Humans; Lactic Acid; Mitochondria; Multiple Sclerosis; Myelin Sheath; Oligodendroglia | 2019 |
1H magnetic resonance spectroscopy in multiple sclerosis and related disorders.
Topics: Aspartic Acid; Biomarkers; Brain; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Protons | 2013 |
Proton magnetic resonance spectroscopy imaging in the study of human brain cancer.
Topics: Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Choline; Creatinine; Glioblastoma; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Necrosis; Positron-Emission Tomography; Protons | 2009 |
[Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].
Topics: Aspartic Acid; Axons; Brain; Diffusion Magnetic Resonance Imaging; Humans; Image Enhancement; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Nerve Fibers, Myelinated; Reproducibility of Results; Spinal Cord | 2003 |
[Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Protons | 2003 |
Biological indicators of the neurodegenerative phase of multiple sclerosis.
Topics: Aspartic Acid; Axons; Biomarkers; Cytoskeletal Proteins; Humans; Multiple Sclerosis; Nerve Degeneration | 2003 |
Imaging neuronal and axonal degeneration in multiple sclerosis.
Topics: Aspartic Acid; Atrophy; Axons; Brain; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Nerve Degeneration; Radiography | 2003 |
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
Topics: 14-3-3 Proteins; Actins; Amyloid beta-Protein Precursor; Apolipoproteins E; Aspartic Acid; Axons; Biomarkers; Humans; Hydroxycholesterols; Multiple Sclerosis; Nerve Degeneration; Phosphopyruvate Hydratase; Predictive Value of Tests; tau Proteins; Tubulin | 2005 |
1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review.
Topics: Aspartic Acid; Brain; Creatine; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 2005 |
N-acetyl-L-aspartate in multiple sclerosis.
Topics: Animals; Aspartic Acid; Axons; Biomarkers; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2006 |
MR spectroscopy in multiple sclerosis.
Topics: Aspartic Acid; Brain Chemistry; Choline; Creatine; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 2007 |
Magnetic resonance imaging and spectroscopy in multiple sclerosis.
Topics: Aspartic Acid; Brain; Disability Evaluation; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Spinal Cord | 1995 |
Correlations of evoked potentials with MR imaging and MR spectroscopy in multiple sclerosis.
Topics: Aspartic Acid; Brain; Choline; Creatine; Evoked Potentials; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Humans; Lactates; Lipids; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Neural Conduction | 1998 |
Imaging axonal damage in multiple sclerosis by means of MR spectroscopy.
Topics: Animals; Aspartic Acid; Axons; Central Nervous System; Disability Evaluation; Disease Progression; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 2000 |
Proton MR spectroscopy in multiple sclerosis.
Topics: Aspartic Acid; Brain; Choline; Creatine; Disability Evaluation; Disease Progression; Energy Metabolism; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Retrograde Degeneration | 2000 |
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences.
Topics: Aspartic Acid; Atrophy; Axons; Brain; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Nerve Degeneration; Neurons | 2001 |
Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution.
Topics: Aspartic Acid; Axons; Brain; Disability Evaluation; Disease Progression; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Neurologic Examination | 2001 |
Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
Topics: Animals; Aspartic Acid; Brain; Choline; Humans; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 1991 |
16 trial(s) available for n-acetylaspartic acid and Multiple Sclerosis
Article | Year |
---|---|
1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis.
Topics: Adult; Analysis of Variance; Aspartic Acid; Cervical Vertebrae; Creatine; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Reproducibility of Results; Spinal Cord; Young Adult | 2013 |
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Creatinine; Disability Evaluation; Endpoint Determination; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Quinolones; Thalamus; Treatment Outcome; Young Adult | 2014 |
The effects of interferon beta-1a on proton MR spectroscopic imaging in patients with multiple sclerosis, a controlled study, preliminary results.
Topics: Adjuvants, Immunologic; Adult; Aspartic Acid; Biomarkers; Brain Mapping; Central Nervous System; Choline; Creatine; Disability Evaluation; Female; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Nerve Fibers, Myelinated; Outcome Assessment, Health Care; Pilot Projects; Treatment Outcome; Young Adult | 2008 |
Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Body Water; Brain Chemistry; Cohort Studies; Creatine; Disease Progression; Female; Humans; Interferon Type I; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Recombinant Proteins; Recurrence | 2003 |
Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis.
Topics: Adaptation, Physiological; Adult; Aspartic Acid; Axons; Brain; Brain Mapping; Cerebral Cortex; Female; Fingers; Frontal Lobe; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Nerve Net; Nervous System Diseases; Psychomotor Performance; Reference Values; Somatosensory Cortex; Syndrome | 2003 |
Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients.
Topics: Adult; Aspartic Acid; Atrophy; Axons; Biomarkers; Cerebral Cortex; Choline; Cognition Disorders; Creatine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuropsychological Tests | 2003 |
Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Choline; Corpus Callosum; Creatine; Diffusion; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Nerve Fibers, Myelinated; Recurrence; Remission, Spontaneous; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2003 |
Axonal damage in multiple sclerosis patients with high versus low expanded disability status scale score.
Topics: Adult; Aspartic Acid; Atrophy; Axons; Biomarkers; Brain; Disability Evaluation; Humans; Magnetic Resonance Imaging; Matched-Pair Analysis; Middle Aged; Multiple Sclerosis; Retrospective Studies; Severity of Illness Index; Spinal Cord | 2004 |
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
Topics: Adolescent; Adult; Aged; Algorithms; Aspartic Acid; Biomarkers; Brain; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neuroglia; Neurons; Neurotransmitter Agents; Tissue Distribution | 2005 |
Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Aspartic Acid; Cerebral Cortex; Creatine; Female; Fluoxetine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 2006 |
High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Mapping; Choline; Creatine; Diagnosis, Differential; Encephalitis; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Models, Biological; Multiple Sclerosis; Nerve Fibers, Myelinated; Optic Neuritis; Predictive Value of Tests; Prospective Studies; Protons | 2008 |
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.
Topics: Adult; Aspartic Acid; Axons; Brain; Creatine; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Risk Assessment; Statistics, Nonparametric | 1997 |
Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions.
Topics: Acute Disease; Adult; Aged; Aspartic Acid; Brain; Chronic Disease; Contrast Media; Creatine; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Phosphoric Monoester Hydrolases; Reference Values; Regression Analysis | 2000 |
Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter.
Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Calibration; Cerebrospinal Fluid; Choline; Creatine; Dipeptides; Epilepsy; Female; Glutamic Acid; Glutamine; Humans; Inositol; Lactic Acid; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Phantoms, Imaging; Regression Analysis; Sensitivity and Specificity | 2000 |
Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Alanine; Amino Acids; Aspartic Acid; Biomarkers; Choline; Corpus Callosum; Female; Humans; Isoleucine; Leucine; Lipoma; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Proteins; Threonine; Valine | 2001 |
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.
Topics: Adjuvants, Immunologic; Adult; Aspartic Acid; Biomarkers; Diffuse Axonal Injury; Female; Humans; Injections, Subcutaneous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Recurrence; Treatment Outcome | 2001 |
105 other study(ies) available for n-acetylaspartic acid and Multiple Sclerosis
Article | Year |
---|---|
Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopy.
Topics: Adult; Aspartic Acid; Atrophy; Creatine; Diffusion Magnetic Resonance Imaging; Energy Metabolism; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine; Thalamus; White Matter | 2018 |
Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent
Topics: Adult; Aged; Aspartic Acid; Axons; Brain; Female; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Nerve Degeneration; Young Adult | 2017 |
Erythropoietin Upregulates Brain Hemoglobin Expression and Supports Neuronal Mitochondrial Activity.
Topics: Animals; Aspartic Acid; Brain; Cell Respiration; Cuprizone; Disease Models, Animal; Electron Transport Complex III; Erythropoietin; Hemoglobins; Histones; Lysine; Male; Methylation; Mice, Inbred C57BL; Mitochondria; Models, Biological; Multiple Sclerosis; Myelin Basic Protein; Myelin Sheath; Neurons; Up-Regulation | 2018 |
Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis.
Topics: Adult; Aspartic Acid; Atrophy; Disease Progression; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Severity of Illness Index; Thalamus; Young Adult | 2019 |
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Topics: Adult; Aspartic Acid; Case-Control Studies; Cerebrovascular Circulation; Creatine; Disability Evaluation; Female; Humans; Linear Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Statistics, Nonparametric; Tritium | 2013 |
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2013 |
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Topics: Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Prodromal Symptoms; Protons; Risk; Syndrome; Young Adult | 2013 |
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
Topics: Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Female; Humans; Lactic Acid; Leukoencephalopathies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Young Adult | 2013 |
Decreased NAA in gray matter is correlated with decreased availability of acetate in white matter in postmortem multiple sclerosis cortex.
Topics: Adult; Aged; Aged, 80 and over; Antimycin A; Aspartic Acid; Autopsy; Axons; Cell Line, Tumor; Female; Humans; Male; Middle Aged; Mitochondria; Motor Cortex; Multiple Sclerosis; Myelin Sheath; Nerve Fibers, Myelinated; Neurons | 2013 |
Magnetic resonance spectroscopy findings as related to fatigue and cognitive performance in multiple sclerosis patients with mild disability.
Topics: Adult; Aspartic Acid; Cognition Disorders; Disabled Persons; Fatigue; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Nerve Fibers, Myelinated; Young Adult | 2014 |
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
Topics: Adult; Aspartic Acid; Cerebral Cortex; Creatine; Disability Evaluation; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Prognosis; Young Adult | 2014 |
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.
Topics: Adult; Aspartic Acid; Atrophy; Biomarkers; Case-Control Studies; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Severity of Illness Index | 2014 |
In vivo evidence of glutamate toxicity in multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Female; Follow-Up Studies; Glutamic Acid; History, Ancient; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis | 2014 |
N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Biomarkers; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Neurofilament Proteins; Prognosis | 2014 |
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Topics: Animals; Antibodies, Monoclonal; Aspartic Acid; Axons; Brain; Brain Stem; Disease Models, Animal; Humans; Magnetic Resonance Spectroscopy; Membrane Glycoproteins; Mice; Multiple Sclerosis; Spinal Cord; Statistics, Nonparametric; Theilovirus; Viral Envelope Proteins | 2015 |
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Topics: Adult; Aged; Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Choline; Creatine; Female; Glutathione; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2015 |
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Topics: Animals; Aspartic Acid; Cognition Disorders; Dipeptides; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamate Carboxypeptidase II; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organophosphorus Compounds; Severity of Illness Index | 2016 |
Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.
Topics: Adult; Aspartic Acid; Creatine; Fatigue; Female; Humans; Middle Aged; Multiple Sclerosis; Pons; Proton Magnetic Resonance Spectroscopy | 2016 |
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Topics: Adult; Aspartic Acid; Axons; Brain; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Retinal Neurons; Sensitivity and Specificity; Tomography, Optical Coherence; White Matter | 2016 |
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Topics: Acetyltransferases; Animals; Aspartic Acid; Cells, Cultured; Central Nervous System; Chromatography, Liquid; Female; Gene Expression Regulation; Histones; Humans; Ketoglutaric Acids; Male; Methylation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiple Sclerosis; Myelin Sheath; Neurons; Oligodendroglia; Postmortem Changes; Tandem Mass Spectrometry | 2017 |
Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Neuromyelitis Optica; White Matter | 2017 |
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Topics: Amino Acids; Aspartic Acid; Axons; Biomarkers; Cohort Studies; Disease Progression; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Nerve Degeneration; Neurofilament Proteins; tau Proteins | 2009 |
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Biomarkers; Brain; Brain Chemistry; Cell Survival; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Severity of Illness Index; Young Adult | 2009 |
MR spectroscopy indicates diffuse multiple sclerosis activity during remission.
Topics: Adult; Aspartic Acid; Brain Chemistry; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Neuroglia; Remission Induction; Young Adult | 2009 |
The brake on neurodegeneration: Increased mitochondrial metabolism in the injured MS spinal cord.
Topics: Aspartic Acid; Cervical Vertebrae; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Mitochondria; Multiple Sclerosis; Nerve Degeneration; Organ Size; Reactive Oxygen Species; Spinal Cord; Time Factors | 2010 |
Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.
Topics: Adenosine Triphosphate; Aspartic Acid; Astrocytes; Brain; Case-Control Studies; Creatine Kinase, BB Form; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Models, Biological; Multiple Sclerosis; Phosphocreatine; Postmortem Changes | 2010 |
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Computer Simulation; Female; Follow-Up Studies; Gene Frequency; Genetic Variation; Genome-Wide Association Study; Genotype; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Models, Genetic; Multiple Sclerosis; Oxidoreductases Acting on Sulfur Group Donors; Polymorphism, Single Nucleotide; Statistics as Topic; Sulfatases | 2010 |
Proton MRS of large multiple sclerosis lesions reveals subtle changes in metabolite T(1) and area.
Topics: Aspartic Acid; Choline; Humans; Inositol; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Protons; Water | 2010 |
Global N-acetylaspartate declines even in benign multiple sclerosis.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Down-Regulation; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Protons; Tissue Distribution; Young Adult | 2011 |
Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.
Topics: Adult; Aspartic Acid; Cognition Disorders; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Neurons; Neuropsychological Tests; Young Adult | 2011 |
Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Demography; Humans; Magnetic Resonance Imaging; Middle Aged; Models, Statistical; Multiple Sclerosis; Nerve Fibers; Retina; Visual Cortex; Young Adult | 2011 |
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.
Topics: Aspartic Acid; Biomarkers; Brain; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index | 2012 |
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Mapping; Child; Choline; Contrast Media; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Gadolinium DTPA; Glutamic Acid; Glutamine; Humans; Image Enhancement; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Young Adult | 2011 |
Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis.
Topics: Animals; Aspartic Acid; Axons; beta 2-Microglobulin; Brain; Brain Stem; CD8 Antigens; Disease Models, Animal; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Multiple Sclerosis; Recovery of Function; Spinal Cord; Theilovirus; Time Factors | 2012 |
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Topics: Adult; Aspartic Acid; Choline; Diffusion; Diffusion Tensor Imaging; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy.
Topics: Adult; Aspartic Acid; Axons; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Humans; Intracellular Fluid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Young Adult | 2012 |
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex)].
Topics: Adolescent; Adult; Aspartic Acid; Brain Chemistry; Creatine; Female; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Nerve Degeneration; Neuroprotective Agents; Neuropsychological Tests; Retrospective Studies; Young Adult | 2012 |
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Topics: Aspartic Acid; Brain; Choline; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inositol; Magnetic Resonance Imaging; Multiple Sclerosis; Nerve Fibers, Myelinated; Propylene Glycols; Sphingosine; Young Adult | 2012 |
Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Protons | 2002 |
Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
Topics: Adult; Aspartic Acid; Atrophy; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Occipital Lobe; Parietal Lobe; Recurrence; Water | 2002 |
3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.
Topics: Adult; Aspartic Acid; Brain; Cohort Studies; Corpus Callosum; Cross-Sectional Studies; Echo-Planar Imaging; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Protons; Reproducibility of Results | 2002 |
Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
Topics: Adult; Alleles; Apolipoprotein E4; Apolipoproteins E; Aspartic Acid; Brain; Cohort Studies; Female; Follow-Up Studies; Genotype; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Protons | 2003 |
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Brain; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Time Factors | 2003 |
Brain damage when multiple sclerosis is diagnosed clinically.
Topics: Aspartic Acid; Atrophy; Brain; Brain Damage, Chronic; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 2003 |
MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.
Topics: Aspartic Acid; Atrophy; Brain; Case-Control Studies; Creatinine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Protons | 2003 |
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Topics: Animals; Aspartic Acid; Axons; Benzoxazines; Cannabinoids; Cyclohexanols; Dizocilpine Maleate; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Gene Deletion; Humans; Mice; Mice, Transgenic; Monomeric GTP-Binding Proteins; Morpholines; Multiple Sclerosis; N-Methylaspartate; Naphthalenes; Nerve Degeneration; Nuclear Proteins; Receptors, Cannabinoid; Receptors, Drug; Receptors, N-Methyl-D-Aspartate; Retina; Saccharomyces cerevisiae Proteins; Spinal Cord; Uveitis | 2003 |
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Brain Chemistry; Creatine; Cross-Sectional Studies; Fatigue; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2004 |
Reduced N-acetylaspartate levels and cognitive decline.
Topics: Alleles; Apolipoproteins E; Aspartic Acid; Brain Chemistry; Cognition Disorders; Disease Progression; Humans; Multiple Sclerosis | 2004 |
Disappearing "T1 black holes" in an animal model of multiple sclerosis.
Topics: Animals; Aspartic Acid; Brain; Brain Chemistry; Cardiovirus Infections; Choline; Creatine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Phosphocreatine | 2004 |
Neuronal cell injury precedes brain atrophy in multiple sclerosis.
Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Chemistry; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neurons; Severity of Illness Index; Time Factors | 2004 |
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
Topics: Adolescent; Adult; Aspartic Acid; Biomarkers; Brain; Creatine; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine; Prospective Studies; Syndrome | 2004 |
MR spectroscopy of cervical spinal cord in patients with multiple sclerosis.
Topics: Adult; Aspartic Acid; Case-Control Studies; Cervical Vertebrae; Choline; Creatine; Female; Humans; Inositol; Lactic Acid; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Spinal Cord | 2004 |
Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
Topics: Adult; Aspartic Acid; Astrocytes; Atrophy; CD3 Complex; Cell Communication; Cells, Cultured; Central Nervous System; Coculture Techniques; Cohort Studies; Disease Progression; Endothelial Cells; Female; Humans; Interferon-beta; Magnetic Resonance Spectroscopy; Male; Microglia; Multiple Sclerosis; Nerve Growth Factor; T-Lymphocytes; Wallerian Degeneration | 2005 |
(1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Energy Metabolism; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mathematical Computing; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Reference Values; Software | 2006 |
MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis.
Topics: Adult; Aged; Aspartic Acid; Cerebral Cortex; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Thalamus | 2006 |
Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Echo-Planar Imaging; Female; Glutamic Acid; Humans; Lactic Acid; Male; Middle Aged; Multiple Sclerosis; Protons | 2007 |
N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
Topics: Adult; Aspartic Acid; Female; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Severity of Illness Index; Statistics, Nonparametric | 2007 |
Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study.
Topics: Adult; Analysis of Variance; Aspartic Acid; Brain Mapping; Case-Control Studies; Choline; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Occipital Lobe; Protons; Thalamus | 2007 |
Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
Topics: Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neuroglia; Osmolar Concentration | 2007 |
"Absolute" quantification in magnetic resonance spectroscopy: validation of a clinical protocol in multiple sclerosis.
Topics: Adult; Algorithms; Aspartic Acid; Biomarkers; Brain; Choline; Diagnosis, Computer-Assisted; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Brain; Case-Control Studies; Creatine; Feasibility Studies; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Male; Middle Aged; Monitoring, Physiologic; Multiple Sclerosis; Peptides; Statistics, Nonparametric | 2008 |
Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients.
Topics: Adult; Aspartic Acid; Biomarkers; Creatinine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Protons; Reproducibility of Results; Sensitivity and Specificity | 2008 |
High resolution proton NMR spectroscopy of multiple sclerosis lesions.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Cadaver; Creatine; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Protons; Reference Values | 1995 |
Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Choline; Cohort Studies; Creatine; Demyelinating Diseases; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Phosphocreatine; Signal Processing, Computer-Assisted | 1994 |
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
Topics: Aspartic Acid; Axons; Brain; Creatine; Follow-Up Studies; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Pilot Projects; Recurrence; Severity of Illness Index | 1994 |
Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine; Phosphorus | 1994 |
Automated processing for proton spectroscopic imaging using water reference deconvolution.
Topics: Artifacts; Aspartic Acid; Body Water; Brain; Choline; Creatine; Electronic Data Processing; Fourier Analysis; Humans; Hydrogen; Image Enhancement; Lactates; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Phosphocreatine; Protons; Water | 1994 |
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.
Topics: Adult; Aspartic Acid; Creatine; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1994 |
Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.
Topics: Adult; Aged; Aspartic Acid; Axons; Cerebellar Ataxia; Cerebellum; Genes, Dominant; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis | 1995 |
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.
Topics: Adult; Aspartic Acid; Brain Diseases; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Time Factors | 1996 |
Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation.
Topics: Aspartic Acid; Basal Ganglia; Brain; Cerebral Cortex; Cerebrospinal Fluid; Choline; Confidence Intervals; Creatine; Gyrus Cinguli; Humans; Hydrogen; Image Enhancement; Linear Models; Lipid Metabolism; Magnetic Resonance Imaging; Multiple Sclerosis; Parietal Lobe; Temporal Lobe; Thalamus | 1996 |
Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T.
Topics: Adult; Aspartic Acid; Astrocytes; Axons; Brain; Cell Membrane; Cerebral Ventricles; Choline; Creatine; Evaluation Studies as Topic; Female; Humans; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Recurrence | 1996 |
Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
Topics: Adult; Aged; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; Humans; Inositol; Lactates; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine | 1996 |
Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
Topics: Adult; Aspartic Acid; Brain; Brain Diseases; Brain Edema; Choline; Chronic Disease; Creatine; Demyelinating Diseases; Encephalitis; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Protons | 1996 |
In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis.
Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Brain Diseases; Choline; Clinical Trials as Topic; Creatine; Discriminant Analysis; Humans; Image Enhancement; Inositol; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Protons | 1996 |
Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
Topics: Aspartic Acid; Brain; Creatine; Disease Progression; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Theoretical; Multiple Sclerosis; Recurrence; Reference Values | 1996 |
Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.
Topics: Adult; Aspartic Acid; Axons; Brain; Creatine; Disabled Persons; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Recurrence | 1997 |
A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging.
Topics: Adult; Aged; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 1995 |
Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Choline; Female; Gadolinium; Humans; Image Enhancement; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 1998 |
Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Disease Progression; Female; Follow-Up Studies; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination | 1998 |
Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
Topics: Aspartic Acid; Axons; Brain; Creatine; Disability Evaluation; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Neurological; Multiple Sclerosis; Phosphocreatine; Reference Values; Time Factors; Tissue Distribution | 1998 |
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
Topics: Aspartic Acid; Axons; Brain; Creatine; Disability Evaluation; Disease Progression; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Recurrence | 1998 |
Quantitative spectroscopic imaging of the human brain.
Topics: Aspartic Acid; Brain Chemistry; Brain Mapping; Cerebral Ventricles; Choline; Computer Graphics; Creatine; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Reference Values | 1998 |
Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology.
Topics: Adult; Analysis of Variance; Aspartic Acid; Attention; Biomarkers; Case-Control Studies; Chi-Square Distribution; Cognition Disorders; Creatine; Female; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Male; Memory, Short-Term; Middle Aged; Multiple Sclerosis; Neural Pathways; Neuropsychological Tests; Pattern Recognition, Visual; Volition | 1999 |
Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.
Topics: Adult; Algorithms; Aspartic Acid; Brain; Choline; Creatine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Phosphocreatine | 1999 |
Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Creatine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine | 1999 |
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.
Topics: Acute Disease; Adult; Aspartic Acid; Axons; Brain; Creatine; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neural Pathways; Protons; Time Factors | 1999 |
Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.
Topics: Adult; Aspartic Acid; Axons; Biopsy, Needle; Blood-Brain Barrier; Brain; Cell Division; Choline; Demyelinating Diseases; Diagnosis, Differential; Dominance, Cerebral; Female; Gliosis; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Neuroglia | 1999 |
Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.
Topics: Adult; Aged; Aspartic Acid; Axons; Electric Stimulation; Female; Humans; Internal Capsule; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Movement Disorders; Multiple Sclerosis; Neural Conduction | 2000 |
Total brain N-acetylaspartate: a new measure of disease load in MS.
Topics: Adolescent; Adult; Aspartic Acid; Biomarkers; Brain; Cell Survival; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neurons; Reference Values; Reproducibility of Results; Severity of Illness Index | 2000 |
Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis.
Topics: Adult; Aged; Aspartic Acid; Axons; Female; Functional Laterality; Humans; Internal Capsule; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Movement Disorders; Multiple Sclerosis; Myelin Sheath; Stroke | 2000 |
A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis.
Topics: Adolescent; Adult; Aged; Aging; Aspartic Acid; Brain Chemistry; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine | 2000 |
Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine | 2000 |
Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.
Topics: Aspartic Acid; Axons; Fingers; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Motor Cortex; Movement; Multiple Sclerosis; Nerve Degeneration; Nerve Fibers, Myelinated; Neuronal Plasticity; Recovery of Function | 2000 |
Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Axons; Chronic Disease; Disability Evaluation; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Spinal Cord | 2000 |
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Topics: Adolescent; Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Nerve Degeneration; Tritium | 2001 |
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
Topics: Adult; Aspartic Acid; Atrophy; Axons; Brain; Chromatography, High Pressure Liquid; Creatine; Disability Evaluation; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Severity of Illness Index; Spinal Cord; Time Factors | 2001 |
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
Topics: Adult; Aspartic Acid; Brain; Creatine; Disability Evaluation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Models, Neurological; Multiple Sclerosis; Predictive Value of Tests | 2001 |
Cognitive dysfunction lateralizes with NAA in multiple sclerosis.
Topics: Adult; Aspartic Acid; Axons; Brain; Cognition Disorders; Disability Evaluation; Female; Functional Laterality; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Severity of Illness Index | 2001 |
Editorial commentary to Narayanan et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.
Topics: Adjuvants, Immunologic; Aspartic Acid; Clinical Trials as Topic; Diffuse Axonal Injury; Disease Progression; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Multiple Sclerosis; Reproducibility of Results; Research Design; Treatment Outcome | 2001 |
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
Topics: Acute Disease; Adult; Aspartic Acid; Biopsy; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Female; Glioma; Humans; Lactates; Lactic Acid; Magnetic Resonance Imaging; Multiple Sclerosis; Tomography, X-Ray Computed | 1992 |
Proton magnetic resonance spectroscopy and multiple sclerosis.
Topics: Aspartic Acid; Humans; Lipids; Magnetic Resonance Imaging; Multiple Sclerosis | 1991 |
Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis.
Topics: Acute Disease; Adult; Aspartic Acid; Brain; Choline; Chronic Disease; Female; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis | 1991 |
Human brain proton localized NMR spectroscopy in multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine | 1991 |
Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.
Topics: Aspartic Acid; Brain; Chronic Disease; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Protons | 1990 |